A novel miR-198-based mimic as a potential therapeutic against pancreatic ductal adenocarcinoma (PDAC). This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not ...

A public-private consortium has been created to investigate the potential food safety and quality issues posed by microbial contaminants in plant-based food products. Partners in the project will look ...

The University of Texas MD Anderson Cancer Center and Federation Bio today announced a strategic collaboration to design and manufacture a complex, synthetic microbial consortium with the goal of ...

ARTISTRY-3: Effect of nemvaleukin alfa with a less frequent IV dosing schedule as monotherapy and in combination with pembrolizumab and impact on the tumor microenvironment (TME) in patients (pts) ...